Viemed Healthcare reported second quarter 2026 financial results on August 3, 2026, achieving record net revenues of $78.1 million, a 23.9% year-over-year increase. Net income attributable to the company was $2.8 million, or $0.07 per diluted share, while Adjusted EBITDA totaled $13.7 million. The company raised its full-year 2026 net revenue guidance to $314–$320 million and revised Adjusted EBITDA expectations to $64–$68 million. Operational highlights included a record ventilator patient count of 12,635 and significant growth in PAP therapy patients (up 44% year-over-year). During the quarter, Viemed repurchased 530,802 shares for $5.1 million and repaid $2.2 million of its term loan, ending with $10.7 million in cash and $6.4 million in long-term debt. Viemed Healthcare operates in the home medical equipment and post-acute healthcare services industry, providing respiratory, chronic care, and women’s health solutions.